These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1926674)

  • 61. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A; Mearini E; Del Zingaro M; Porena M
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical and urodynamic rationale of the overactive bladder neurophysiological model].
    Danilov VV; Danilova TI; Danilov VV
    Urologiia; 2010; (4):15-20. PubMed ID: 20967977
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacologic effect of thiphenamil HCl on lower urinary tract function of healthy asymptomatic volunteers.
    Constantinou CE
    Urol Int; 1992; 48(3):293-8. PubMed ID: 1589919
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions.
    de Sèze M; Wiart L; Joseph PA; Dosque JP; Mazaux JM; Barat M
    Neurourol Urodyn; 1998; 17(5):513-23. PubMed ID: 9776014
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trospium chloride: an effective option for medical treatment of bladder overactivity.
    Füsgen I; Hauri D
    Int J Clin Pharmacol Ther; 2000 May; 38(5):223-34. PubMed ID: 10839466
    [No Abstract]   [Full Text] [Related]  

  • 66. Clinical reevaluation of the effect of oxybutynin chloride on uninhibited neurogenic and reflex neurogenic bladder.
    Kawabe K; Abe S; Kanda T; Tei K
    Urol Int; 1986; 41(1):16-20. PubMed ID: 3962017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity.
    Prasad KV; Vaidyanathan S
    Br J Urol; 1993 Nov; 72(5 Pt 2):719-22. PubMed ID: 8281402
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intravesical capsaicin for treatment of detrusor hyperreflexia.
    Fowler CJ; Beck RO; Gerrard S; Betts CD; Fowler CG
    J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):169-73. PubMed ID: 8126498
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of cerebrolysin on bladder function after spinal cord injury in female Wistar rats.
    Abolhasanpour N; Eidi A; Hajebrahimi S; Reyhani-Rad S; Hashim H
    Int J Urol; 2019 Sep; 26(9):917-923. PubMed ID: 31317583
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Urodynamic effects of intravesical instillation of atropine and phentolamine in patients with detrusor hyperactivity.
    Ekström B; Andersson KE; Mattiasson A
    J Urol; 1993 Jan; 149(1):155-8. PubMed ID: 8417203
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Combined treatment of voiding disorders in women with m-cholinolytic and alpha 1-adrenoblocker].
    Danilov VV; Vol'nykh IIu; Abdullaeva CK; Danilova TI
    Urologiia; 2004; (3):49-52. PubMed ID: 15199816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detrusor hyperreflexia--are there two types?
    Lord A; Eastwood H
    Age Ageing; 1994 Jan; 23(1):32-3. PubMed ID: 8010169
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inappropriate rise in heart rate caused by intravenous administration of trospium chloride during upper gastrointestinal endoscopy.
    Hasselkus W
    Endoscopy; 1998 Aug; 30(6):580. PubMed ID: 9746172
    [No Abstract]   [Full Text] [Related]  

  • 74. [Overactive bladder as a mask of chronic prostatitis].
    Kul'chavenia EV; Brizhatiuk EV; Breusov AA
    Urologiia; 2012; (6):43-4, 46. PubMed ID: 23379238
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Pharmacological evaluation of efficacy and safety of propiverine hydrochloride in patients of overactive bladder--relationship between urodynamic observation and propiverine pharmacokinetics--].
    Sugiyama T; Shimizu N; Hashimoto K; Yoshioka N; Hanai T; Matsumoto S; Uemura H
    Nihon Hinyokika Gakkai Zasshi; 2005 Nov; 96(7):670-7. PubMed ID: 16363652
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia.
    Goessl C; Knispel HH; Fiedler U; Härle B; Steffen-Wilke K; Miller K
    Urology; 1998 Jan; 51(1):94-8. PubMed ID: 9457296
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [24-h dynamics of urination in patients with overactive urinary bladder].
    Danilov VV; Danilova TI; Danilov VV; Vodop'ianova OA; Vasil'chenko AV; Besedin SV
    Urologiia; 2007; (4):45-7, 49. PubMed ID: 17915449
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Trospium chloride (Sanctura): another anticholinergic for overactive bladder.
    Med Lett Drugs Ther; 2004 Aug; 46(1188):63-4. PubMed ID: 15289745
    [No Abstract]   [Full Text] [Related]  

  • 79. Detrusor hyperreflexia in neurogenic bladder disorders caused by localized partial lesions of the spinal cord and cauda equina.
    Gunasekera WS; Richardson AE; Seneviratne KN; Eversden ID
    Surg Neurol; 1983 Jul; 20(1):63-6. PubMed ID: 6306854
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transurethral intravesical electrotherapy for neurogenic bladder dysfunction in children with myelodysplasia: a prospective, randomized clinical trial.
    Boone TB; Roehrborn CG; Hurt G
    J Urol; 1992 Aug; 148(2 Pt 2):550-4. PubMed ID: 1640520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.